LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation

The lymphocyte adaptor protein (LNK) is a negative regulator of cytokine and growth factor signaling. The rs3184504 variant in SH2B3 reduces LNK function and is linked to cardiovascular, inflammatory, and hematologic disorders including stroke. In mice, deletion of Lnk causes inflammation and oxidat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular research 2024-07, Vol.120 (8), p.899-913
Hauptverfasser: Murphy, Matthew B, Yang, Zhenjiang, Subati, Tuerdi, Farber-Eger, Eric, Kim, Kyungsoo, Blackwell, Daniel J, Fleming, Matthew R, Stark, Joshua M, Van Amburg, Joseph C, Woodall, Kaylen K, Van Beusecum, Justin P, Agrawal, Vineet, Smart, Charles D, Pitzer, Ashley, Atkinson, James B, Fogo, Agnes B, Bastarache, Julie A, Kirabo, Annet, Wells, Quinn S, Madhur, Meena S, Barnett, Joey V, Murray, Katherine T
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 913
container_issue 8
container_start_page 899
container_title Cardiovascular research
container_volume 120
creator Murphy, Matthew B
Yang, Zhenjiang
Subati, Tuerdi
Farber-Eger, Eric
Kim, Kyungsoo
Blackwell, Daniel J
Fleming, Matthew R
Stark, Joshua M
Van Amburg, Joseph C
Woodall, Kaylen K
Van Beusecum, Justin P
Agrawal, Vineet
Smart, Charles D
Pitzer, Ashley
Atkinson, James B
Fogo, Agnes B
Bastarache, Julie A
Kirabo, Annet
Wells, Quinn S
Madhur, Meena S
Barnett, Joey V
Murray, Katherine T
description The lymphocyte adaptor protein (LNK) is a negative regulator of cytokine and growth factor signaling. The rs3184504 variant in SH2B3 reduces LNK function and is linked to cardiovascular, inflammatory, and hematologic disorders including stroke. In mice, deletion of Lnk causes inflammation and oxidative stress. We hypothesized that Lnk-/- mice are susceptible to atrial fibrillation (AF) and that rs3184504 is associated with AF and AF-related stroke in humans. During inflammation, reactive lipid dicarbonyls are a major component of oxidative injury, and we further hypothesized that these mediators are critical drivers of the AF substrate in Lnk-/- mice. Lnk-/- or wild-type (WT) mice were treated with vehicle or 2-hydroxybenzylamine (2-HOBA), a dicarbonyl scavenger, for 3 months. Compared to WT, Lnk-/- mice displayed increased AF duration that was prevented by 2-HOBA. In the Lnk-/- atria, action potentials were prolonged with reduced transient outward K+ current, increased late Na+ current, and reduced peak Na+ current, proarrhythmic effects that were inhibited by 2-HOBA. Mitochondrial dysfunction, especially for complex I, was evident in Lnk-/- atria, while scavenging lipid dicarbonyls prevented this abnormality. Tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were elevated in Lnk-/- plasma and atrial tissue, respectively, both of which caused electrical and bioenergetic remodeling in vitro. Inhibition of soluble TNF-α prevented electrical remodeling and AF susceptibility, while IL-1β inhibition improved mitochondrial respiration but had no effect on AF susceptibility. In a large database of genotyped patients, rs3184504 was associated with AF, as well as AF-related stroke. These findings identify a novel role for LNK in the pathophysiology of AF in both experimental mice and in humans. Moreover, reactive lipid dicarbonyls are critical to the inflammatory AF substrate in Lnk-/- mice and mediate the proarrhythmic effects of pro-inflammatory cytokines, primarily through electrical remodeling.
doi_str_mv 10.1093/cvr/cvae036
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929541903</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929541903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c177t-b8c825c326265052e0c216fb163e397097effdbf8f8dad34c4011f8595c6c9a93</originalsourceid><addsrcrecordid>eNo9kEtLAzEURoMotlZX7iVLQcbmMXkttagViy7UlYshk0kwMo-aZIT-e1NaXVwuFw4f3z0AnGN0jZGic_MT8miLKD8AUywYKygp2SGYIoRkwSmnE3AS41c-GRPlMZhQSYUoJZ-Cj9Xz0_x1SW4pbIcY4eCgG3uT_NBD35tgdbQRxjEau06-9q1PG5gG2I3B9xbqvoGfY6d7qFPwuoXO18G3rd4GnIIjp9toz_Z7Bt7v794Wy2L18vC4uFkVBguRiloaSZihhBPOECMWGYK5qzGnliqBlLDONbWTTja6oaUpEcZOMsUMN0orOgOXu9x1GL5HG1PV-dw3t-jtMMaKKKJYiRWiGb3aoSbkb4N11Tr4TodNhVG1tVllm9XeZqYv9sFj3dnmn_3TR38B1VhxtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929541903</pqid></control><display><type>article</type><title>LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Murphy, Matthew B ; Yang, Zhenjiang ; Subati, Tuerdi ; Farber-Eger, Eric ; Kim, Kyungsoo ; Blackwell, Daniel J ; Fleming, Matthew R ; Stark, Joshua M ; Van Amburg, Joseph C ; Woodall, Kaylen K ; Van Beusecum, Justin P ; Agrawal, Vineet ; Smart, Charles D ; Pitzer, Ashley ; Atkinson, James B ; Fogo, Agnes B ; Bastarache, Julie A ; Kirabo, Annet ; Wells, Quinn S ; Madhur, Meena S ; Barnett, Joey V ; Murray, Katherine T</creator><creatorcontrib>Murphy, Matthew B ; Yang, Zhenjiang ; Subati, Tuerdi ; Farber-Eger, Eric ; Kim, Kyungsoo ; Blackwell, Daniel J ; Fleming, Matthew R ; Stark, Joshua M ; Van Amburg, Joseph C ; Woodall, Kaylen K ; Van Beusecum, Justin P ; Agrawal, Vineet ; Smart, Charles D ; Pitzer, Ashley ; Atkinson, James B ; Fogo, Agnes B ; Bastarache, Julie A ; Kirabo, Annet ; Wells, Quinn S ; Madhur, Meena S ; Barnett, Joey V ; Murray, Katherine T</creatorcontrib><description>The lymphocyte adaptor protein (LNK) is a negative regulator of cytokine and growth factor signaling. The rs3184504 variant in SH2B3 reduces LNK function and is linked to cardiovascular, inflammatory, and hematologic disorders including stroke. In mice, deletion of Lnk causes inflammation and oxidative stress. We hypothesized that Lnk-/- mice are susceptible to atrial fibrillation (AF) and that rs3184504 is associated with AF and AF-related stroke in humans. During inflammation, reactive lipid dicarbonyls are a major component of oxidative injury, and we further hypothesized that these mediators are critical drivers of the AF substrate in Lnk-/- mice. Lnk-/- or wild-type (WT) mice were treated with vehicle or 2-hydroxybenzylamine (2-HOBA), a dicarbonyl scavenger, for 3 months. Compared to WT, Lnk-/- mice displayed increased AF duration that was prevented by 2-HOBA. In the Lnk-/- atria, action potentials were prolonged with reduced transient outward K+ current, increased late Na+ current, and reduced peak Na+ current, proarrhythmic effects that were inhibited by 2-HOBA. Mitochondrial dysfunction, especially for complex I, was evident in Lnk-/- atria, while scavenging lipid dicarbonyls prevented this abnormality. Tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were elevated in Lnk-/- plasma and atrial tissue, respectively, both of which caused electrical and bioenergetic remodeling in vitro. Inhibition of soluble TNF-α prevented electrical remodeling and AF susceptibility, while IL-1β inhibition improved mitochondrial respiration but had no effect on AF susceptibility. In a large database of genotyped patients, rs3184504 was associated with AF, as well as AF-related stroke. These findings identify a novel role for LNK in the pathophysiology of AF in both experimental mice and in humans. Moreover, reactive lipid dicarbonyls are critical to the inflammatory AF substrate in Lnk-/- mice and mediate the proarrhythmic effects of pro-inflammatory cytokines, primarily through electrical remodeling.</description><identifier>ISSN: 0008-6363</identifier><identifier>ISSN: 1755-3245</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvae036</identifier><identifier>PMID: 38377486</identifier><language>eng</language><publisher>England</publisher><ispartof>Cardiovascular research, 2024-07, Vol.120 (8), p.899-913</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c177t-b8c825c326265052e0c216fb163e397097effdbf8f8dad34c4011f8595c6c9a93</cites><orcidid>0000-0002-2297-2703 ; 0000-0003-0391-3916 ; 0000-0001-8580-9359 ; 0000-0002-1342-4457</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38377486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murphy, Matthew B</creatorcontrib><creatorcontrib>Yang, Zhenjiang</creatorcontrib><creatorcontrib>Subati, Tuerdi</creatorcontrib><creatorcontrib>Farber-Eger, Eric</creatorcontrib><creatorcontrib>Kim, Kyungsoo</creatorcontrib><creatorcontrib>Blackwell, Daniel J</creatorcontrib><creatorcontrib>Fleming, Matthew R</creatorcontrib><creatorcontrib>Stark, Joshua M</creatorcontrib><creatorcontrib>Van Amburg, Joseph C</creatorcontrib><creatorcontrib>Woodall, Kaylen K</creatorcontrib><creatorcontrib>Van Beusecum, Justin P</creatorcontrib><creatorcontrib>Agrawal, Vineet</creatorcontrib><creatorcontrib>Smart, Charles D</creatorcontrib><creatorcontrib>Pitzer, Ashley</creatorcontrib><creatorcontrib>Atkinson, James B</creatorcontrib><creatorcontrib>Fogo, Agnes B</creatorcontrib><creatorcontrib>Bastarache, Julie A</creatorcontrib><creatorcontrib>Kirabo, Annet</creatorcontrib><creatorcontrib>Wells, Quinn S</creatorcontrib><creatorcontrib>Madhur, Meena S</creatorcontrib><creatorcontrib>Barnett, Joey V</creatorcontrib><creatorcontrib>Murray, Katherine T</creatorcontrib><title>LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>The lymphocyte adaptor protein (LNK) is a negative regulator of cytokine and growth factor signaling. The rs3184504 variant in SH2B3 reduces LNK function and is linked to cardiovascular, inflammatory, and hematologic disorders including stroke. In mice, deletion of Lnk causes inflammation and oxidative stress. We hypothesized that Lnk-/- mice are susceptible to atrial fibrillation (AF) and that rs3184504 is associated with AF and AF-related stroke in humans. During inflammation, reactive lipid dicarbonyls are a major component of oxidative injury, and we further hypothesized that these mediators are critical drivers of the AF substrate in Lnk-/- mice. Lnk-/- or wild-type (WT) mice were treated with vehicle or 2-hydroxybenzylamine (2-HOBA), a dicarbonyl scavenger, for 3 months. Compared to WT, Lnk-/- mice displayed increased AF duration that was prevented by 2-HOBA. In the Lnk-/- atria, action potentials were prolonged with reduced transient outward K+ current, increased late Na+ current, and reduced peak Na+ current, proarrhythmic effects that were inhibited by 2-HOBA. Mitochondrial dysfunction, especially for complex I, was evident in Lnk-/- atria, while scavenging lipid dicarbonyls prevented this abnormality. Tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were elevated in Lnk-/- plasma and atrial tissue, respectively, both of which caused electrical and bioenergetic remodeling in vitro. Inhibition of soluble TNF-α prevented electrical remodeling and AF susceptibility, while IL-1β inhibition improved mitochondrial respiration but had no effect on AF susceptibility. In a large database of genotyped patients, rs3184504 was associated with AF, as well as AF-related stroke. These findings identify a novel role for LNK in the pathophysiology of AF in both experimental mice and in humans. Moreover, reactive lipid dicarbonyls are critical to the inflammatory AF substrate in Lnk-/- mice and mediate the proarrhythmic effects of pro-inflammatory cytokines, primarily through electrical remodeling.</description><issn>0008-6363</issn><issn>1755-3245</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kEtLAzEURoMotlZX7iVLQcbmMXkttagViy7UlYshk0kwMo-aZIT-e1NaXVwuFw4f3z0AnGN0jZGic_MT8miLKD8AUywYKygp2SGYIoRkwSmnE3AS41c-GRPlMZhQSYUoJZ-Cj9Xz0_x1SW4pbIcY4eCgG3uT_NBD35tgdbQRxjEau06-9q1PG5gG2I3B9xbqvoGfY6d7qFPwuoXO18G3rd4GnIIjp9toz_Z7Bt7v794Wy2L18vC4uFkVBguRiloaSZihhBPOECMWGYK5qzGnliqBlLDONbWTTja6oaUpEcZOMsUMN0orOgOXu9x1GL5HG1PV-dw3t-jtMMaKKKJYiRWiGb3aoSbkb4N11Tr4TodNhVG1tVllm9XeZqYv9sFj3dnmn_3TR38B1VhxtA</recordid><startdate>20240702</startdate><enddate>20240702</enddate><creator>Murphy, Matthew B</creator><creator>Yang, Zhenjiang</creator><creator>Subati, Tuerdi</creator><creator>Farber-Eger, Eric</creator><creator>Kim, Kyungsoo</creator><creator>Blackwell, Daniel J</creator><creator>Fleming, Matthew R</creator><creator>Stark, Joshua M</creator><creator>Van Amburg, Joseph C</creator><creator>Woodall, Kaylen K</creator><creator>Van Beusecum, Justin P</creator><creator>Agrawal, Vineet</creator><creator>Smart, Charles D</creator><creator>Pitzer, Ashley</creator><creator>Atkinson, James B</creator><creator>Fogo, Agnes B</creator><creator>Bastarache, Julie A</creator><creator>Kirabo, Annet</creator><creator>Wells, Quinn S</creator><creator>Madhur, Meena S</creator><creator>Barnett, Joey V</creator><creator>Murray, Katherine T</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2297-2703</orcidid><orcidid>https://orcid.org/0000-0003-0391-3916</orcidid><orcidid>https://orcid.org/0000-0001-8580-9359</orcidid><orcidid>https://orcid.org/0000-0002-1342-4457</orcidid></search><sort><creationdate>20240702</creationdate><title>LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation</title><author>Murphy, Matthew B ; Yang, Zhenjiang ; Subati, Tuerdi ; Farber-Eger, Eric ; Kim, Kyungsoo ; Blackwell, Daniel J ; Fleming, Matthew R ; Stark, Joshua M ; Van Amburg, Joseph C ; Woodall, Kaylen K ; Van Beusecum, Justin P ; Agrawal, Vineet ; Smart, Charles D ; Pitzer, Ashley ; Atkinson, James B ; Fogo, Agnes B ; Bastarache, Julie A ; Kirabo, Annet ; Wells, Quinn S ; Madhur, Meena S ; Barnett, Joey V ; Murray, Katherine T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c177t-b8c825c326265052e0c216fb163e397097effdbf8f8dad34c4011f8595c6c9a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murphy, Matthew B</creatorcontrib><creatorcontrib>Yang, Zhenjiang</creatorcontrib><creatorcontrib>Subati, Tuerdi</creatorcontrib><creatorcontrib>Farber-Eger, Eric</creatorcontrib><creatorcontrib>Kim, Kyungsoo</creatorcontrib><creatorcontrib>Blackwell, Daniel J</creatorcontrib><creatorcontrib>Fleming, Matthew R</creatorcontrib><creatorcontrib>Stark, Joshua M</creatorcontrib><creatorcontrib>Van Amburg, Joseph C</creatorcontrib><creatorcontrib>Woodall, Kaylen K</creatorcontrib><creatorcontrib>Van Beusecum, Justin P</creatorcontrib><creatorcontrib>Agrawal, Vineet</creatorcontrib><creatorcontrib>Smart, Charles D</creatorcontrib><creatorcontrib>Pitzer, Ashley</creatorcontrib><creatorcontrib>Atkinson, James B</creatorcontrib><creatorcontrib>Fogo, Agnes B</creatorcontrib><creatorcontrib>Bastarache, Julie A</creatorcontrib><creatorcontrib>Kirabo, Annet</creatorcontrib><creatorcontrib>Wells, Quinn S</creatorcontrib><creatorcontrib>Madhur, Meena S</creatorcontrib><creatorcontrib>Barnett, Joey V</creatorcontrib><creatorcontrib>Murray, Katherine T</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murphy, Matthew B</au><au>Yang, Zhenjiang</au><au>Subati, Tuerdi</au><au>Farber-Eger, Eric</au><au>Kim, Kyungsoo</au><au>Blackwell, Daniel J</au><au>Fleming, Matthew R</au><au>Stark, Joshua M</au><au>Van Amburg, Joseph C</au><au>Woodall, Kaylen K</au><au>Van Beusecum, Justin P</au><au>Agrawal, Vineet</au><au>Smart, Charles D</au><au>Pitzer, Ashley</au><au>Atkinson, James B</au><au>Fogo, Agnes B</au><au>Bastarache, Julie A</au><au>Kirabo, Annet</au><au>Wells, Quinn S</au><au>Madhur, Meena S</au><au>Barnett, Joey V</au><au>Murray, Katherine T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2024-07-02</date><risdate>2024</risdate><volume>120</volume><issue>8</issue><spage>899</spage><epage>913</epage><pages>899-913</pages><issn>0008-6363</issn><issn>1755-3245</issn><eissn>1755-3245</eissn><abstract>The lymphocyte adaptor protein (LNK) is a negative regulator of cytokine and growth factor signaling. The rs3184504 variant in SH2B3 reduces LNK function and is linked to cardiovascular, inflammatory, and hematologic disorders including stroke. In mice, deletion of Lnk causes inflammation and oxidative stress. We hypothesized that Lnk-/- mice are susceptible to atrial fibrillation (AF) and that rs3184504 is associated with AF and AF-related stroke in humans. During inflammation, reactive lipid dicarbonyls are a major component of oxidative injury, and we further hypothesized that these mediators are critical drivers of the AF substrate in Lnk-/- mice. Lnk-/- or wild-type (WT) mice were treated with vehicle or 2-hydroxybenzylamine (2-HOBA), a dicarbonyl scavenger, for 3 months. Compared to WT, Lnk-/- mice displayed increased AF duration that was prevented by 2-HOBA. In the Lnk-/- atria, action potentials were prolonged with reduced transient outward K+ current, increased late Na+ current, and reduced peak Na+ current, proarrhythmic effects that were inhibited by 2-HOBA. Mitochondrial dysfunction, especially for complex I, was evident in Lnk-/- atria, while scavenging lipid dicarbonyls prevented this abnormality. Tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were elevated in Lnk-/- plasma and atrial tissue, respectively, both of which caused electrical and bioenergetic remodeling in vitro. Inhibition of soluble TNF-α prevented electrical remodeling and AF susceptibility, while IL-1β inhibition improved mitochondrial respiration but had no effect on AF susceptibility. In a large database of genotyped patients, rs3184504 was associated with AF, as well as AF-related stroke. These findings identify a novel role for LNK in the pathophysiology of AF in both experimental mice and in humans. Moreover, reactive lipid dicarbonyls are critical to the inflammatory AF substrate in Lnk-/- mice and mediate the proarrhythmic effects of pro-inflammatory cytokines, primarily through electrical remodeling.</abstract><cop>England</cop><pmid>38377486</pmid><doi>10.1093/cvr/cvae036</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-2297-2703</orcidid><orcidid>https://orcid.org/0000-0003-0391-3916</orcidid><orcidid>https://orcid.org/0000-0001-8580-9359</orcidid><orcidid>https://orcid.org/0000-0002-1342-4457</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0008-6363
ispartof Cardiovascular research, 2024-07, Vol.120 (8), p.899-913
issn 0008-6363
1755-3245
1755-3245
language eng
recordid cdi_proquest_miscellaneous_2929541903
source Oxford University Press Journals All Titles (1996-Current)
title LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T11%3A48%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LNK/SH2B3%20loss%20of%20function%20increases%20susceptibility%20to%20murine%20and%20human%20atrial%20fibrillation&rft.jtitle=Cardiovascular%20research&rft.au=Murphy,%20Matthew%20B&rft.date=2024-07-02&rft.volume=120&rft.issue=8&rft.spage=899&rft.epage=913&rft.pages=899-913&rft.issn=0008-6363&rft.eissn=1755-3245&rft_id=info:doi/10.1093/cvr/cvae036&rft_dat=%3Cproquest_cross%3E2929541903%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2929541903&rft_id=info:pmid/38377486&rfr_iscdi=true